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The  "echo"  viruses  share  certain  properties  with  other  enteric  viruses, 
namely the polioviruses and  Coxsackie  viruses, and  yet  exhibit  no  pathoge- 
nicity for common laboratory animals.  The present studies were undertaken to 
learn  whether  echo  virus  Types  6  and  4  which  cause  aseptic  meningitis  in 
human beings (1-5) would infect the highest laboratory primate available, the 
chimpanzee, and whether the exposure would give rise to an illness. 
In the study being reported, only inapparent infections were demonstrated, 
the patterns of infection being similar to those found earlier for the poliomye- 
litis  (6,  7)  and  Coxsackie viruses  (8).  The  infections  were  characterized  by 
virus carriage in the stools and in the throat of the fed animals, and antibody 
responses in all animals infected. 
Materials and Methods 
Virus Used.--Type 6 D'Amori strain was used in its 10th passage in monkey kidney tissue 
culture (TC). The virus stock had a titer of 10  ~.T TCD60 per ml. Type 4 Pesascek virus was 
used at the 9th and 10th passage levels in monkey kidney after having had 9 earlier passages 
in monkey testis. The titers of these two stocks were 10  e.° and 106.a per ml., respectively. Both 
virus strains had  been isolated from cases with the aseptic meningitis syndrome in New 
England (1, 9). 
Exposure to  Virus.--Five chimpanzees,  each about 2  years old, were  exposed  to large 
doses of both viruses, two orally and three parenterally. The interval between the exposures 
was 2~ months. Each animal was infected by the same route in the two exposures. 
Type 6 Exposure: On 2 consecutive  days, 10 ml. of undiluted TC fluid were given to 
each of two animals, being mixed with fresh banana before breakfast. The total  TCDs0 fed 
was  109.o for each chimpanzee.  Each of 3 animals was inoculated intramuscularly with 
1.0 ml. and intracutaneously with 0.6 ml. of undiluted TC fluid. The latter was divided 
into six piqflrea of 0.1 ml. each on the thigh. The total TCD~0 given for each animal was 
107  .9. 
Type 4 Exposure: Almost the same routines were followed as with the Type 6 virus, 
except that 20 ml. of the undiluted TC fluid was fed on two occasions. The total TCDs0 
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of virus given was  107.s. The 3  parenterally inoculated chimpanzees each received 108.t 
TCD~0 administered in the same way as with the Type 6 virus. 
Observation o/animals.--Rectal temperatures were taken daily in the forenoon for a period 
of 2 weeks after exposure. The chimpanzees were examined daily for other suggestive signs; 
i.e., pharyngeal injection, anorexia, lymphoadenopathy, skin rash, loose bowels, etc. 
Virus Isolation.--Stools,  throat swabs, and blood specimens were collected almost daily 
for 12 days after Type 6 infection and 13 days after Type 4 infection, and weekly thereafter, 
as deemed necessary. Chimpanzee 4-2 was intractable and attempts to isolate virus from its 
throat were abandoned after collecting two postinfection specimens. 
Fresh stoois were collected each morning and frozen at  -20°C. for further processing. 3 
gin. of each stool specimen were suspended in 27 ml. of water by mechanical shaking for an 
hour. After the centrifugation at 3,000 R.P.M. for 60 minutes, penicillin and streptomycin 
were added to the supernate in the concentrations of 500 uuits/ml, and 500 ug/ml., respec- 
tively. These specimens were used immediately or kept frozen at  --20°C.  until tested. 
One cotton swab was used to swab the throat of each chimpanzee. It was extracted as 
follows in 1.0 ml. of Hanks's balanced salt solution (BSS) containing antibiotics (peniciUin, 
200 units/m1.; streptomycin, 200 ~g./ml.; tetracycline, 25 t~g./ml; and mycostatin, 100 units/ 
ml.). Each cotton swab was transferred from the wooden applicator into the barrel of a  1.0 
ml. syringe. Then 1 ml. of BSS was swished back and forth several times through the swab, 
each time squeezing the swab with the plunger. 
Blood was drawn usually from the forearm veins but in a few instances from the femoral 
vessels. The blood was mixed with an equal volume of sterile distilled water, shaken vigor- 
ously, and stored in the frozen state at  -20°C.  It was not treated further before testing. 
Monl'~ey Kidney Cultures.--Trypsinized  rhesus monkey kidney cultures were employed for 
detection of virus by methods already described (9, 10). Five tubes were used for each speci- 
men, each being inoculated with 0.1 ml. The cuitures were checked microscopically for cyto- 
pathic changes for at least 10 days. Positive specimens after the Type 6 infection were then 
titrated. In doubtful eases TC fluid was transferred to fresh tubes. 
On occasion, 3 oz. bottle cultures were used to detect small amounts of virus. Monolayex 
cultures in prescription bottles were inoculated with 1.0 ml. of the stool specimens, and 20 
hours later fluids were changed with fresh medium  and the cultures were  again inoculated 
with 1.0 ml. of the same specimen. 
Identif~ation  of tke Isolated Viruses.--Neutralization  tests were performed on a  number 
of the isolates. For Type 6 we used a  1:100 dilution of hyperimmune rabbit antiserum which 
at this dilution contained 100 antibody units against the D'Amori strain, and about 108 to 
104 TCDso of virus  as  chailenge. All tests for Type  6  were  carried out by inoculation of 
monolayer cultures in tubes. 
Owing to the diificulty experienced in the Type 4 neutralization tests in tubes, reduction 
in plaque titer in bottle cultures was adopted (10, 11). A 1:30 hyperimmune serum was mixed 
with about 500 and 50 PHI (plaque-forming units) of the first passage virus in monkey kidney 
culture, and plated under agar in bottle cultures (12). 
Serum  Neutralization  Test.--Pre-  and  postinfection  serum  specimens  were  obtained. 
About 30 ml. of blood were taken at 2 week intervals, and the serum was stored in the frozen 
state. For Type 6 antibodies 0.5 ml. of D'Amori virus containing an estimated 100 TCDn0 
per 0.1 ml. was mixed with 0.5 ml. aliquots of several 2- or 4-fold serum dilutions. The dil- 
uent for both virus and serum was BSS. The mixture was incubated at room temperature 
for 1 hour, and then 0.2 ml. of each mixture was inoculated into each of 3 or 4  TC tubes, 
containing 1.0 ml. of M-E  1 maintenance medium. For the parallel titration of virus, 0.1 ml. 
1 A maintenance medium used in this laboratory since 1952.  It contains 0.5 per cent lac- 
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of each 10-fold virus dilution was inoculated per culture. The final readings were made on the 
7th day, when the control titration showed that  100  TCDs0 was present in the test dose. 
The 50 per cent end-point titer was calculated by the method of Reed and Muench, and was 
indicated as serum dilution before mixing with  virus.  Serum neutralization tests against 
6  ~, 6 't, and a few other echo virus types were performed in the same way. 
Because of the difficulty in demonstrating Type 4  neutralizing antibody, four different 
methods were employed  :--Method I  was the technic given above for the Type 6 neutraliza- 
tion. Method II was taken from the procedure in use in Syverton's laboratory at the Uni- 
versity of Minnesota. Virus  dilutions were prepared in M-E medium to contain 100 TCDs0 
in 0.5  ml., and 2.5  ml. mixed with equal volumes of 3-fold dilutions of serum also diluted 
in the same medium. While the mixture was incubated at  room temperature for  1 hour, 
the fluid was drained from monkey kidney cultures. The drained cultures were then inoc- 
ulated with 1.0 ml. of the serum-virus mixture, 4  tubes being used for each mixture. The 
procedure was similar to Method I  but allowed us to use a five times greater ratio of serum 
to virus. 
With  Method  I  the  sera  after  Type  4  infection  gave  negative  results  at  the  low- 
est serum-dilution, 1:4.  With Method II  all  the specimens tested over an 8  week period 
also gave negative results at the lowest dilution, 1:10. This would correspond to 1:2 serum 
dilutions for Method I.  Thus,  as  the next step, we adopted the virus dilution technic in 
which the neutralization index was determined as a  measure of antibody titer. Undiluted 
serum was mixed with equal amounts of several 10-fold dilutions of virus. After incubation 
at room temperature for 1 hour, 0.2  ml. of each mixture was inoculated into each of four 
tubes. The results were read on the 5th day. The results are presented as the logarithm of 
the neutralization index, that is,  the logarithm of the difference between the control virus 
titer  and  the  virus  titered  in  the  presence  of  the serum.  Even with this technic anti- 
body  titers  were  found  to  be  low.  Therefore,  as  the  fourth  method,  plaque  neu- 
tralization  tests were  carried  out.  5-fold  serum  dilutions from 1:2  to  1:250  were mixed 
with an estimated 100 PFU of virus. Equal volumes of diluted serum and virus in BSS were 
mixed. The mixture was incubated for 1 hour at room temperature, and 0.2  ml. of each mix- 
ture was inoculated into each of two drained bottle cultures. After an adsorption period 
of 1 hour at 37°C.,  the monolayers were covered with agar (11).  The overlay contained 1.5 
per cent agar, 2.0 per cent calf serum, 1:60,000  neutral red, and 0.225 per cent sodium bi- 
carbonate in final concentration in Earle's salt solution. 440  units of penicillin, 440/zg.  of 
streptomycin, and  110  units of mycostatin were included in each milliliter of the overlay. 
The bottles were left about  1 hour at  room temperature for solidification  of the overlay, 
inverted, and incubated at 37°C.  The plaque counts of both bottles at each serum dilution 
were compared with the number of plaques in the control group without serum, 80 per cent 
reduction in plaque count was taken as the lower limit of significant neutralization, and the 
highest dilution of serum which gave such neutralization was considered as the titer of the 
serum. 
Complement  Fixation  Test.--The details of the plate CF technic as used in this labora- 
tory have already been described (12).  The D'Amori antigen was in the form of undiluted 
TC fluid  which had been harvested at the time of strong CPE (cytopathogenic effect) and 
centrifuged at 3000 R.P.M. for 30 minutes. The antigen was grown in washed monolayer cul- 
tures in the presence of C-E medium (0.01 per cent cysteine, 0.25 per cent glucose,  Earle's 
salt solution). The antigen was standardized by performing box titrations with a monkey im- 
mune serum, and was found to contain 8 units per 20 c.mm. drop of TC fluid. The chimpanzee 
sera were tested in 2-fold falling dilutions against 8 units of echo-6 antigen and also as con- 
trols  against  8  units  of  each  of  3  types  of  polinantigens  grown under  similar  condi- 
tions. Avidity scores were calculated for each dilution of serum. The CF titer of the serum 680  INFECTION  WITH  ECHO  VIRUSES 
was taken as the highest dilution of serum which fixed 2 units of complement in the pres- 
ence of 8 units of antigen. 
RESULTS 
Type 6 (D'Amori) Infection.2--Neither the chimpanzees fed nor those injected with 
virus parenterally manifested any illness including fever, pharyngeal injection, skin 
TABLE I 
Isolation of Virus from Stool, Throat, and Blood after Exposure to Echo Type 6 (D'Amori)  Virus 
Dates of 
infection 
[uly 13- 
14, 1956 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
14 
21 
Oral infection  Parentersl infection 
Stool  Throat  Blood  Stool 
No.  No. 
4-0  4-1 
4.7* 3.5* 
5.3  3.7 
5.3  2.7 
4.2 
2.5  3.5 
2.7*2.2 
+  +* 
+  + 
+  -- 
--  + 
+  + 
Throat 
No.  No. 
4-0  4-1 
1.4' 3.7 
3.5  3.5 
3.0  3.5 
3.0*3.0 
2.7  2.0* 
1.7  2.0* 
2.7  2.0 
1.5  1.4" 
1.5  11.5 
1.7  1.2" 
1.4'10.6 
0.6 
Blood 
No.  No. 
4-0  4-1 
No. 
4-2 
No. 
4-4 
No.  No.  No.  No. 
4-5  4-2  4-4  4-5 
--  m 
No. No.  No. 
4-2  4-4  4-5 
1.5*  -- 
* Isolates which were typed. All were identified as echo Type 6 by neutralization  tests. 
Titers are expressed as log TCDs0 per gram stool, per throat swab, and per milliliter blood, 
respectively.  +  indicates positive isolation, but stool was not titrated. 
rash, etc., during the period of observation. The recovery of virus is shown in Table 
I. Virus could be isolated from the upper and lower ends of the alimentary tract for 
12 days in the orally infected animals, but not from the parenterally infected animals, 
except for a  single blood specimen taken 2 days after exposure.  This cannot be ac- 
cepted as evidence of true viremia following viral multiplication  as is usually observed 
in Coxsackie  or virulent poliovirus infections in primates (8,  13,  14). Because chim- 
panzee  4-5  already  had  neutralizing antibodies in  its  pre-inoculation serum,  the 
negative results in the blood of this animal are of little significance. 
The amount of virus fed to each animal was 0.5  X  109 TCDs0 on each of 2 succes- 
sive days. On the morning after the second feeding, only a small fraction of the virus 
fed could be recovered in the stools and throat. The titers were relatively high, 10  s'5 
to  104.7 for feces, and 10  L+ to  10  sa for the throat swab extracts. Larger amounts of 
We wish to acknowledge the assistance of Dr. T. Kuwata, Chiba University,  Chiba, 
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virus were excreted during the first 4  to 5 days, then the virus levels in these sites 
declined gradually during the next week. There seems little doubt that the virus had 
multiplied after the oral exposure, particularly in view of the control experiments in 
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FIG.  1.  Development of neutralizing antibodies in chimpanzees  after inoculation with 
echo virus Type 6. Those animals having their first experience with this virus made similar 
antibody  responses.  Chimpanzee 4-5,  with  pre-existing  antibodies  to  echo-6  or  a  related 
virus, responded to  "boostering"  with high antibody production;  this animal was the only 
one whose postinoculation serum neutralized echo-6'  and echo-6" also  (see Fig.  2). 
ECHO--6  ECHO-4 
64,000 
Ch~.'~'~ 
the stability of the D'Amori virus at 37 °. Undiluted tissue culture fluid which titered 
107n per ml., decreased in titer to 102"s per ml. in 1 week, and was entirely negative 
in 2 weeks. 
Neutralizing Antlb~ies.--As  can be seen in Fig. 1, all animals developed neutraliz- 
ing antibodies, with peak titers being reached within 2  to 4  weeks. The antibodies 682  INFECTION  WITH  ECHO  VIRUSES 
persisted at their maximum levels for more than 6 months, and were not influenced 
by the subsequent exposure to Type 4 v/ms. The antibody response was almost the 
same in the fed and injected an/reals except for chimpanzee 4-5. This parenterally 
infected animal had neutralizing antibodies at a level of 1:64,  in  its pre-inoculation 
serum. The titer rapidly rose to reach 1:50,000 within 2 weeks, which happened to 
be even higher than the titer of a hyperimmune serum being used by us as a reference 
standard. 
As shown in Fig. 2, chimpanzee 4-5 developed antibodies which also neutralized 
the  antigenic  variants,  echo  6'  and  6"  viruses.  The  pre-inoculation serum  of 4-5 
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FIO. 3.  Development of complement-fixing  antibodies in chimpanzees  after inoculation 
with echo virus Type 6. The animals which lacked previous experience with this virus all 
made CF responses reaching a level of 8 to 16, and faring after 40 to 56 days. Chimpanzee 
4-5, with pre-existing neutralizing antibodies, also had pre-existing CF antibodies; these rose 
to a level of 256, which was maintained throughout the period of observation. 
exhibited a  titer of 1:16 against echo-6' v/rus, and  the peak titer after inoculation 
rose to 1:1024.  Against echo-6" virus, no antibodies were found before inoculation, 
but afterwards the 4 week serum had a  titer of 1:64, and was still 1:16 in the 28th 
week. In the other chimpanzees no neutralization occurred at the lowest dilution of 
serum tested, 1:4, against these viruses, even after second infection with echo-4 virus. 
Pre, 2  week, and 6  week sera of chimpanzee 4-5 were also tested against eeho-1 
(Farouk) and  echo-5  (Noyce) v/ruses with no neutralization being detected at  1:4 
serum dilution. Polio antibodies were present to varying degrees (greatest for Type 
2) in view of the fact that the animals had been vaccinated with commercial vaccine 
some months before being used for the present experiments. The level of polio anti- 
bodies was not influenced by the echo virus infections. 
Comfle~,~-F~b:ing A~ibodies.--Development of CF antibodies in all five chim- 
panzees is shown in Fig. 3. Again chimpanzee 4-5 manifested evidence of prior echo-6 HEIHACHI  ITOH  AND  JOSEPH  L.  MELNICK  683 
infection, for a low level of antibody was present in its pre-inoculation serum. By the 
end of 2 weeks the titer rose to a level of 1:256, which was maintained for at least 8 
weeks.  With other  chimpanzees their peak  titers,  ranging from  1:8  to  1:24,  were 
reached  in 2  to 4  weeks.  By the 8th week  they dropped  to  1:4 or were  negative. 
No CF antibodies to the polioviruses developed, even though the animals had been 
TABLE n 
Isolation of Virus from Stool, Throat, and Blood after Exposure to Echo Type 4 (Pesascek) Virus 
Dates of  Days after 
infection  infection 
Oct. 2-3,  Pre 
1956  1 
2 
3 
4 
6 
7 
8 
9 
10 
11 
13 
20 
28 
35 
42 
57 
Oral infection 
Stool  Throat 
~O.  NO. 
4-0  4-1 
Jr*  Jr* 
Jr  Jr 
Jr  Jr 
Jr  - 
Jr 
Jr 
Jr  - 
I' 
No.  No. 
4-0  4-1 
--  Jr 
-  I+ 
Jr  i Jr 
+*  I Jr* 
Jr  Jr 
Jr  Jr 
Jr  - 
Jr  + 
Jr  Jr* 
Jr  - 
Jr  - 
Jr*  -- 
Jr  - 
Jr  - 
Blood  Stool 
No.  No.  No.  No. 
4-0  4-1  4-4  4-5 
Parenteral infection 
Jr* 
-  + 
Throat  Blood 
No.  No  No.  No. 
4-4  4-5  4-4  4-5 
i- 
--  Jr* 
w 
Jr* 
t 
Chimpanzee 4-2 was infected parenterally,  but was not tested  for vires excretion. 
* Isolates which were typed.  All were identified as echo Type 4 by neutralization  tests. 
Jr indicates more than 40 TCDbo per gram stool, 4 TCDs0 per throat swab, and 8 TCDs0 
per milliliter blood. 
sensitized by receiving a  course of commercial poliovaccine several months prior to 
the echo-6 exposure. 
Type 4  (Pesascek)  Infection.--The animals were  exposed  to echo-4  virus 10 weeks 
after the echo-6 had been given. Again no overt illness occurred during the period of 
observation. A picture similar to that of echo-6 infection is shown in Table II. Titra- 
tion of the positive specimens was not carried out, but the  duration of  excretion, 
particularly in the throat,  was adequate to show  that virus multiplication had oc- 
curred. For interpretation of the data in Table II it may be useful to recall, as de- 
scribed under Materials and Methods, that the dose of echo-4 was less than 10 per 
cent of that of echo-6. Thus the duration of virus excretion, especially in chimpanzee 
4-0, is all the more significant. 684  INFECTION WITH  ECHO VIRUSES 
TABLE  III 
Neutralizing Antibodies against Echo Type 4 Virus 
Chimpanzee No. 
4-0 
4-1 
4-2 
4-4 
4-5 
Time of 
bleeding 
wks. 
Pre 
2 
4 
6 
8 
16 
19 
Pre 
2 
4 
6 
8 
16 
19 
Pre 
2 
4 
6 
8 
16 
19 
Pre 
2 
4 
6 
8 
16 
19 
Pre 
2 
4 
6 
8 
16 
19 
Titers by Methods 
I and II* 
(serum diluted,  virus 
held constant) 
Log neutralization  [ 
index 
(virus diluted, serum [ 
held constant) 
0.50 
0.83 
! 
0.33  I 
0.73  i 
0.17 
0.0 
0.50 
1.00 
0.25 
0.50 
0.73 
1.00 
0.50 
0.33 
0.83 
1.00 
0.0 
1.00 
1.17 
1.50 
Titer by" plaque 
method 
<1:2 
<1:2 
1:10 
1:10 
1:10 
<1:2 
1:10 
1:50 
1:50 
<1:2 
I:10 
1:50 
<1:2 
1:I0 
1:50 
1:250 
<1:2 
1:10 
1:50 
1:50 
1:50 
*Zero indicates <1:4 for Method I, and  <1:10 for Method II. Because of the 5-fold 
greater serum to virus ratio in Method II, this would correspond to a  1:2 serum dilution in 
Method I. Also, dissociation upon dilution in Method II is not possible, because the serum- 
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Among the parenterally  infected animals,  4-5 showed virus in the  stools 2  to 3 
days after inoculation and 4-4 in the throat on the 4th day. Again one blood specimen 
was positive, a sample taken 1 day after inoculation of virus. In the fed group, chim- 
panzee 4-0 secreted virus for 35 days in the throat, but only 10 days in the stool and, 
even here, with some intermitteucy. However, less  than 40 TCD~0 in 1 gin. of stool 
would not give a  positive  test  in  the present  experiments,  because of the dilution 
factor in preparing the stool extract. With 4-1, virus excretion was more brief,  that is, 
for 10 days in the throat and only 3 days in stools. 
Neutralizing Antibodies.--The results of neutralization tests carried out by the four 
methods described under Materials and Methods are shown in Table III. By the con- 
ventional test (Method I) all the specimens tested were negative at the lowest dilu- 
TABLE IV 
Neutralizing  Antibody  Response in Chimpanzees Fed Echo Types 2, 3, and  an  Untypable 
Strain (Co) 
Chimpanzee 
A 
B 
C 
Virus 
Echo-2 fed 
Echo-2 recovered 
from stools 
Echo-3 fed 
Echo-3 recovered 
from stools 
Co  fed 
Co recovered from 
stools 
Serum fiters 
Pre-exposure  I  1 month after 
I 
exposure 
0  32 
0  64 
0  32 
0  32 
0  96 
0  32 
Reference antisera 
TYI~2  Type3 
256+  O 
512  0 
512 
0  64 
0  0 
0  0 
tion tested,  1:4. Method II was then employed, in which larger amounts of serum 
were  mixed with  I00 TCDs0,  and  added  to drained  cultures,  as recommended by 
Syverton. Possible dissociation of the antigen-antibody complex which might occur 
in the ordinary method (in which 0.2 ml. of the virus-serum mixture is added to i  ml. 
of fluid)  is thus avoided. Again all sera tested gave negative results at the lowest di- 
lution tested,  I:I0 (equivalent to 1:2 of Method I). 
In the next tests, the neutralization index was determined, using undiluted serum, 
and varying dilutions of virus from i  to  1000 TCDBo. In general,  the indices were 
small, but tended to increase towards 8 and 16 weeks after infection. Tests for neu- 
tralizing antibodies by the plaque reduction method gave better results,  with anti- 
body levels of l:10 to 1:250 being observed. 
There was no significant effect of the exposure to echo-4 virus on the pre-existing 
Type 6  antibody.  Similarly  the echo-6' and  6" antibodies  in chimpanzee 4-5  were 
not influenced by the echo-4 exposure. 
Trials with Types  2,  3,  and an  Untypable Echo  Virus.mThree  other chimpanzees 686  INFECTION WITH  ECHO  VIRUSES 
were each fed an echo virus, each animal receiving 4 to 12 ml. of undiluted TC fluid? 
The animals excreted virus for up to 3 weeks after the exposure. As shown in Table 
IV, the animals  developed specific antibody against the ingested  virus. Because the 
outcome confirmed the pattern est~bl/shed with echo types 4 and 6,  the experiments 
on these 3 animals will not be reported here in any greater detail. 
DISCUSSION 
Infection of chimpanzees with echo viruses followed the pattern established 
with  the  other  enteric viruses,  both  poliomyelitis and  Coxsackie  (6-8).  No 
apparent illness occurred, but infection was readily demonstrated by the pres- 
ence and persistence of virus in the throat and in the feces. It is noteworthy 
that with these enteric viruses, in the orally infected animals virus was found 
in the throat as long as in the intestines/or Type 6, and even longer for Type 
4. In the chimpanzees fed Type 4, virus persisted in  the throat for 10 and 35 
days but in the feces of these animals for 3  and  10 days, respectively.  This 
recalls a  similar observation with the Coxsackie viruses, which was limited to 
type B2, in which carriage of virus in the chimpanzee throat equalled that in 
the lower alimentary tract (8). 
Unlike poliomyelitis virus, which readily finds its way from the skin to the 
gut in the chimpanzee (15), the echo viruses studied were not readily excreted 
into the gut after parenteral infection. In two animals  infected with Type 4, 
virus was found briefly in the alimentary  tract but this was not followed by 
long term carriage. 
The antibody response in the animals was prompt with respect to Type 6. 
As in other viral infections, neutralizing antibodies persisted at high titer for 
the 6 months of the study, while CF antibodies already were at borderline level 
8 weeks after infection. In accord with other observations on echo-4 virus, we 
have found that its antibodies are difficult to detect. This has been true not 
only with postinfection sera, but also with sera of hyperimmunized animals. 
With the latter sera, we have also found that 50-fold higher titers can be ob- 
tained by using the more sensitive plaque reduction method. 
The  one animal,  No. 4-5, with pre-existing  Type 6 antibodies  before we fed it 
virus is worthy of special comment. First it indicates  that chimpanzees may become 
infected naturally by this echo virus. Of course, we have no way of determining  at 
this time whether its first infection occurred in the wilds of Africa or whether it be- 
came infected  during its contacts with man in its period of captivity. It seems un- 
likely that the animal became infected in our laboratory because it was the only one 
of 5 animals with antibodies  and yet all 5 animals had the same laboratory exposure 
prior to the experiments reported. 
Second, chimpanzee 4-5 was the only animal  which produced such extraordinarily 
high antibody titers, 1:50,000. Although  this was an anamnestic response, the level 
s Dr.  Bernardo  Epstein,  Rockefeller Foundation  Fellow in  1954, participated  in  these 
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of antibody reached was as high as, if not higher than, the best levels reached by 
hyperimmunization  of rabbits or monkeys. 
Third, the antibody response of this chimpanzee alone was broad. In addition to 
the high level of Type 6 antibodies, antibodies also developed to antigenic relatives 
of the prototype D'Amori strain, namely echo Types 6' and 6". Antigenic variants 
exist within several echo types. The possibility exists that they may develop in a 
host which is exposed to one type and which gives rise to antibodies against the spe- 
cific type as well as to antigenic variants. The stool specimens of these chimpanzees 
have been made available to Dr. David Karzon, University of Buffalo,  who is deter- 
mining whether the virus excreted late after infection  differed  antigenically  from that 
excreted immediately  after the exposure. 
The polioviruses and the Coxsackie viruses  are characterized  by possessing 
group CF antigens.  One of the purposes of the present experiment  was to de- 
termine whether chimpanzees infected with an echo virus made complement- 
fixing CF antibodies which showed group reactivity with poliovirus antigens. 
The  animals  in  question  had  previously been  inoculated with  commercial 
poliomyelitis vaccine,  and had responded,  but only to Type 2. None of the 5 
animals had CF antibodies to poliovirus in their sera before exposure to echo-6 
and none of them, after exposure to the echo virus,  made poliomeylitis anti- 
bodies, when tested against unheated or heated poliovirus antigens. 
SIY~'~RY 
The oral and parenteral infections of chimpanzees receiving echo Types 6 
and 4 viruses successively are described. The two infections, spaced 2~/~ months 
apart,  and given by the same  route in each  animal, failed  to induce  overt 
disease. The inapparent infections were demonstrated by virus excretion in the 
throat and the stools and the development of neutralizing antibodies.  Comple- 
ment-fixing antibodies also appeared  after Type 6 infection,  but fell more rap- 
idly than the neutralizing antibodies. 
Mter oral infection,  echo-6 virus was  found for equal  periods  in both the 
throat and feces, but echo-4 persisted  in the throat for much  longer periods 
than in the lower bowel. Almost no virus  carriage  occurred  after parenteral 
inoculation. No true viremia was exhibited in any of the animals. 
One of the chimpanzees had neutralizing  antibodies  against Type 6 virus in 
its pre-inoculation  serum. It responded  extraordinarily to the Type 6 exposure, 
developing antibody levels of 1:50,000 to echo-6, of 1:1024 against the echo-6' 
variant, and of 1:64 against the echo 6" variant. 
Although Type  4  antibodies  developed  after  the  exposure,  they proved 
dit~cult to measure by ordinary methods. However, they could be satisfactorily 
assayed by the plaque reduction method. 
Three other chimpanzees fed echo-2, echo-3, and an  untypable echo virus, 
respectively, yielded results confirming those established with Types 4 and 6. 688  INTECTION WITH ECHO VIRUSES 
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